Institutional investors purchased a net $1.4 million shares of GHDX during the quarter ended March 2014 and now own 94.69% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAMBER CAPITAL MANAGEMENT LLC Bought 975.0 Thousand shares of Genomic Health Inc
BAKER BROS. ADVISORS LP Bought 199.3 Thousand shares of Genomic Health Inc
CREDIT SUISSE AG Bought 1.1 Thousand shares of Genomic Health Inc